[Company Logo Image]  

Home
Maggot therapy
Hirudotherapy
Apitherapy
Ichthiotherapy
Protozootherapy
Bacteriotherapy
Helminthotherapy
Sniffer dogs
Biosurgery
Conferences
Newsletters
Executive Members
Constitution
Bibliography
Registration
Search
Sponsorship

NEWSLETTER 2 (August 2000)

I. Fifth International Conference on Biotherapy

The Conference was held in Wurzburg, Germany, on June 29-30, 2000, at Congress Center, the main subject being "Biotherapy and the Skin".

The organizing and scientific committee included Dr. Kosta Y. Mumcuoglu (Chairman), Dr. John C. T. Church (Co-Chairman), Dr. Andrew Jarvis and Dr. Jacqueline Miller.

The Conference was held together with the Forth Congress of the German Wound Healing and Wound Treatment Society (4. Kongress der Deutschen Gesellschaft fuer Wundheilung und Wundbehandlung e.V.) (President: Prof. A. Thiede).

The scientific program, the abstracts and the list of participants and authors were published in our home page.

II. Minutes of IBS Executive Meeting, held on Thursday 29th June, 2000 at 2.00 pm, at the Maritim Conference Centre, Wurzburg, Germany

Those present:

Kostas Y Mumcuoglu [KM] (President and chairman of meeting)

John C.T. Church [JC] (Treasurer and Past President)

Olga Gilyova [OG] (Regional representative)

Carita Hanssen [CH] (Regional representative)

Andrea Andrews [AA] (Committee member)

Andrew Jarvis [AJ] (Secretary)

1) The Meeting

KM commenced by thanking JC and also his colleague Dr. Jacqueline Miller, for their considerable help in organizing the meeting. He went on to point out the real difficulties, which this meeting had presented. KM had sent out thousands of e-mails to hundreds of people in connection with this meeting. KM also thanked Dr. Ron Sherman for broadcasting the news of the meeting. KM reported that Drs Selenev and Nikonov had withdrawn their proposed presentations at the last moment.

2) IBS Web Page

KM thanked his son Michael, who had made a huge contribution to creating the web page. KM appealed to all members to contribute to the page. JC said that the page was superb, and hoped that it could be enlarged, to take in areas such as apitherapy, as promoted for instance by Dr G. Broemenshenk.

CH said she would be happy to have a link to her own web page. KM said that in due course we could extend to veterinary matters, but felt at this stage this should be therapeutic, not diagnostic. KM said we would be keen to include icthiotherapy. JC said this had recently appeared in the BMJ, from Dr Akpinar, and it would be a good topic to add to the web.

JC mentioned the exciting new development of helminthotherapy (treating bowel disease with worms), which again would be an ideal topic for IBS to be involved in.

3) SMTL Web page

KM said he had asked SMTL to close the Biotherapy part of their website to avoid confusion with ours, and Pete Phillips had agreed to do so.

4) Tanzania

KM had been invited (in February 2000) to Moshi, Tanzania, by Prof. Terence Ryan (International Dermatology Foundation) to give a seminar. KM had been met by Prof. Grossmann, and had presented the case for maggot therapy. KM had been received very positively, and as a result, Prof Grossmann had authorized the setting-up of a unit dedicated to providing maggot therapy in Tanzania, to treat the numerous forms of chronic limb infection that were encountered locally. KM said that this was just the sort of start which he had been hoping for, in establishing maggot therapy in developing countries.

KM mentioned Dr. D. Artemov, who is having difficulties in establishing biotherapy (both maggot and leech) in Cyprus. It was mentioned that Mr. J. Goj had set up a lab in Bangkok.

5) Sponsorship

Was discussed. All felt it was preferable to avoid receiving money from healthcare companies, or other sources, with powerful ‘strings attached’

6) Clinical Trials; EWM (European Wound Management Association)

JC said he was going to meet Prof. Christine Moffat, the President of the above body, who wants to set up a UK based trial of larval therapy debridement. On related matters, AA said that Bridgend already had a large list of patients who had received LT.

JC mentioned that Prof. Terence Ryan still held £ 6,000 from the Dunhill Foundation for such studies. There was then a discussion about the practicalities of running any such trial. CH said that some of her work was multi-centre, and that it was very difficult to organize.

7) Treasurer’s Report

JC reported that the IBS funds were about £ 700. He moved that some money be sent to KM to cover some of the costs he had incurred. KM protested that this was not necessary.

8) Larva Therapy Forum

JC presented a document for discussion, proposing an International Larva Therapy Forum (ILTF), whose express aim would be to establish high standards of clinical care, methodology, and outcome reporting, etc. Matters such as sterility of larvae would be addressed by such a body. The ILTF should be very much Internet based. JC was very worried that without some such body, LT would remain fragmented, and could at any time fall into disrepute through poor practice and methodology.

9) Regional Reports

Scandinavia: CH reported that her unit was now selling larvae to other centres, including Norway, and Copenhagen. She was starting to get interest from her orthopaedic colleagues. She had a technician working half time. She had set up a Wound Healing Centre and had obtained some sponsorship for this.

Russia: OG reported that hirudotherapy was still developing in Russia. Her colleagues had organized a conference last September, which 39 people had attended. This was disappointing, but the venue had been Chechnya, so undoubtedly this choice deterred people from attending. There had been some changes in their group, e.g., of the president. Sixteen cities have their own representative in the Association., and there is an educational programme. They treat skin, dental, urological and misellaneous disorders.

10 IBS Constitution.

A new copy of the IBS Constitution was signed by all present.

11 Changes to Committee

Mary Jones had expressed ambivalence about staying on the Committee; there was uncertainty about whether she was coming to the Wurzburg meeting. In the end she had not come, and it was decided that she should be invited to stand down from the Committee.

AA would remain as co-opted member, with the provisional role of “international laboratory monitor”.

Andrew Jarvis, Secretary IBS, 12.7.00

III. Minutes of IBS Annual General Meeting, (AGM), held on Saturday 1st July, 2000, at 11.00 am, at the Maritim Conference Centre, Wurzburg, Germany

Committee members present:

Kostas Y Mumcuoglu [KM] (President and chairman of meeting)

John C.T. Church [JC] (Treasurer and Past President)

Olga Gilyova [OG] (Regional representative)

Andrea Andrews [AA] (Committee member)

Andrews Jarvis [AJ] (Secretary)

1) The Minutes of the previous Annual General Meeting (Porthcawl, South Wales, 10th June1999), were read out and agreed.

2) Chairman’s Business

KM thanked our German hosts. It had been a very amicable meeting with good interaction. He especially thanked the main organizers, Prof. A. Thiede and Dr. P. Wassell. KM asked us to consider whether the principle of our ‘colonizing’ a larger meeting is a good one, or not. There clearly had been good and bad consequences for us. KM said that there had been a huge administrative burden for him, as he had to send out thousands of e-mails.

The IBS Website had now been set up, and was absolutely central to the running and purpose of the Society. KM sincerely thanked his son Michael for the work he had done on Web project. KM stressed that while he was very keen to expand the web pages, there were limits to how much material could reasonably be included.

3) Tanzania

KM reported that he had been invited (in February 2000) to Moshi, Tanzania, by Prof. Terence Ryan (International Dermatology Foundation) to give a seminar. KM had been met by Prof Grossmann and had presented the case for larva therapy. KM had been received very positively, anas a result, Prof Grossmann had authorised the setting-up of a unit dedicated to providing maggot therapy in Tanzania, to treat the numerous forms of chronic limb infection that were encountered locally. A separate, purpbuilt insectarium was being constructed.

4) Past President and Treasurer

JC reported that he had invited Prof. Fin Gottrup to join the IBS as a Scandinavian regional representative. Prof. Teot, who is the President of the French Wound Healing Society, would be invited to join in a similar capacity.

JC stated that the bank balance of the Society currently amounted to approximately £ 700, and that this was unlikely to change much in the immediate future.

5) Next Conference

KM was keen that the next meeting should be in Spring 2001, and proposed a liaison with Prof. Rufli, who is organizing a Swiss Tissue Repair Society Annual Meeting.

A discussion on conference arrangements followed. AA asked whether a sequential meeting was better than a parallel one. JC proposed an intermingling situation with a plenary session (at which all delegates would be present). AJ suggested that a ‘best offer’ should be sought from the possibly two societies, which might collaborate on a joint meeting.

6) Re-election of Officers

JC proposed that all members should be re-appointed to their present posts, except that AA should now become a co-opted member. There were no objections to these two proposals. JC also proposed that Prof Rufli be invited to join as a regional representative. KM undertook to ask Dr Fleischmann to join the Society.

7) Any Other Business

OG suggested that a meeting in Russia be considered. Another proposal was a conference in Morocco, but no firm conclusion was reached on this.

Andrew Jarvis, Secretary IBS, 14.7.00

 

IV. Companies Producing Sterile Maggots

BioMonde GmbH & Co. KG

Wolliner Str. 8, 22143 Hamburg, Germany

Tel.: ++ 49 40 65493439

Fax.: ++ 49 40 65390409

Web-page: http://www.biomonde.de

E-mail: BioMonde@t-online.de

 

Neocura GmbH iG

Im Naturwissenschaftlichen und Medizinischen Institut (NMI)

Markwiesenstrasse 55, 72770 Reutlingen, Germany

Tel.: ++ 49 7071 910388

Fax.: ++ 49 7071 910389

 

The Biosurgical Research Unit

The Surgical Material Testing Laboratory (SMTL),
Princess of Wales Hospital
Coity Road, Bridgend, CF31 1RQ
United Kingdom

Tel: +44 1656 752820
Fax: +44 1656 752830

Web-page: http://www.smtl.co.uk

E-mail: steve@smtl.co.uk

V. Recent Publication in Biotherapy

Sherman, R.A., Hall, M. J. and S. Thomas. 2000. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu. Rev. Entomol. 45: 55-81.

Wolff, H., and C. Hansson. 1999. Larval therapy for a leg ulcer with methicillin-resistant Staphyloccocus aureus. Acta Dermato-Venereolog., 79: 4, 320-321.

Klempa,I. 1999. Biosurgery-revival of the maggot. Chirurg 70: 1285-1286.

Fleischmann, W., Russ, M., Moch, D. and C. Marquardt. 1999. Biosurgery-maggots, are they really the better surgeons? (in German). Chirurg, 70: 1340-6.

Gallenkemper, G. and W. Maier. 1999. Biosurgery in the treatment of problematic wounds. Part I. (in German). Ztschr. Wundbeh. 4: 6-10.

Gallenkemper, G. and W. Maier. 1999. Biosurgery in the treatment of problematic wounds. Part II. (in German). Ztschr. Wundbeh. 4: 38-40.

Rayman, A., Stansfield, G., Woollard, T., Mackie, A. and G. Rayman. 1998. Use of larvae in the treatment of the diabetic necrotic foot. Diabetic Foot, 1: 1, 7...13.

Thomas, S. 1998. A wriggling remedy. Chemistry and Industry, No. 17, 680-683.

Krajacic, A. 1998. Consider using maggots. Todays Surg. Nurse, 20: 28-32.

Wolff,H. and C. Hansson. 1998. A renaissance for maggot therapy of wounds (in Swedish). Lakartidningen, 95: 4468-9.

Root-Bernstein, R. and M. Root-Bernstein. 1997. Honey, mud, maggots, and other medical marvels. MacMilan, London, pp. 279.



Copyright © 2007 Hebrew University, Jerusalem, Israel
Last modified: 01/01/07